Literature DB >> 10517314

Inhibition of HIV-1 infection by zinc group metal compounds.

Y Haraguchi1, H Sakurai, S Hussain, B M Anner, H Hoshino.   

Abstract

Thirty-seven metal compounds were examined for inhibitory activities against infection with human immunodeficiency virus type 1 (HIV-1). Zinc group metal compounds, namely, zinc acetate, zinc chloride, zinc nitrate, cadmium acetate and mercury chloride, showed anti-HIV-1 activities. Cadmium and mercury compounds at 1-10 microg/ml and zinc compounds at 100 microg/ml strongly inhibited HIV-1 infection, although the cadmium, mercury and zinc compounds had severe cytotoxities at 100, 100 and 1000 microg/ml, respectively. They inhibited transcription of HIV-1 RNA and HIV-1 production at concentrations at which they did not affect the growth of HIV-1-producing cells. They had little effect on syncytium formation resulting from cocultivation of uninfected with HIV-1-producing cells. Nor did they affect HIV-1 DNA synthesis following HIV-1 infection. The metal compounds may owe their anti-HIV-1 effects to inhibition of HIV-1 DNA to RNA transcription, rather than inhibition of the adsorption, penetration or reverse transcription step of HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10517314     DOI: 10.1016/s0166-3542(99)00040-6

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  33 in total

1.  Zinc acetate/carrageenan gels exhibit potent activity in vivo against high-dose herpes simplex virus 2 vaginal and rectal challenge.

Authors:  José A Fernández-Romero; Ciby J Abraham; Aixa Rodriguez; Larisa Kizima; Ninochka Jean-Pierre; Radhika Menon; Othell Begay; Samantha Seidor; Brian E Ford; Pedro I Gil; Jennifer Peters; David Katz; Melissa Robbiani; Thomas M Zydowsky
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

2.  Efficacy and toxicity of zinc salts as candidate topical microbicides against vaginal herpes simplex virus type 2 infection.

Authors:  Nigel Bourne; Rachael Stegall; Raquel Montano; Michael Meador; Lawrence R Stanberry; Gregg N Milligan
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

Review 3.  Non-specific microbicide product development: then and now.

Authors:  Joseph W Romano; Melissa Robbiani; Gustavo F Doncel; Thomas Moench
Journal:  Curr HIV Res       Date:  2012-01-01       Impact factor: 1.581

4.  A single dose of a MIV-150/Zinc acetate gel provides 24 h of protection against vaginal simian human immunodeficiency virus reverse transcriptase infection, with more limited protection rectally 8-24 h after gel use.

Authors:  Jessica Kenney; Rachel Singer; Nina Derby; Meropi Aravantinou; Ciby J Abraham; Radhika Menon; Samantha Seidor; Shimin Zhang; Agegnehu Gettie; James Blanchard; Michael Piatak; Jeffrey D Lifson; José A Fernández-Romero; Thomas M Zydowsky; Melissa Robbiani
Journal:  AIDS Res Hum Retroviruses       Date:  2012-07-30       Impact factor: 2.205

5.  Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase.

Authors:  Nidhi Kaushik; Chandru Subramani; Saumya Anang; Rajagopalan Muthumohan; Baibaswata Nayak; C T Ranjith-Kumar; Milan Surjit
Journal:  J Virol       Date:  2017-10-13       Impact factor: 5.103

6.  Blood cell, liver function, and response changes by PEG-interferon-alpha2b plus ribavirin with polaprezinc therapy in patients with chronic hepatitis C.

Authors:  Ke Ih Kim; Soo Ryang Kim; Noriko Sasase; Yoko Akimoto; Mao Shikata; Aya Ohtani; Teruko Hirooka; Kazuhiko Tanaka
Journal:  Hepatol Int       Date:  2008-01-11       Impact factor: 6.047

7.  A novel intravaginal ring to prevent HIV-1, HSV-2, HPV, and unintended pregnancy.

Authors:  Shweta R Ugaonkar; Asa Wesenberg; Jolanta Wilk; Samantha Seidor; Olga Mizenina; Larisa Kizima; Aixa Rodriguez; Shimin Zhang; Keith Levendosky; Jessica Kenney; Meropi Aravantinou; Nina Derby; Brooke Grasperge; Agegnehu Gettie; James Blanchard; Narender Kumar; Kevin Roberts; Melissa Robbiani; José A Fernández-Romero; Thomas M Zydowsky
Journal:  J Control Release       Date:  2015-06-17       Impact factor: 9.776

8.  Triple therapy of interferon and ribavirin with zinc supplementation for patients with chronic hepatitis C: a randomized controlled clinical trial.

Authors:  Hideyuki Suzuki; Hitoshi Takagi; Naondo Sohara; Daisuke Kanda; Satoru Kakizaki; Ken Sato; Masatomo Mori
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

9.  Effect of Human Immunodeficiency Virus on Trace Elements in the Brain.

Authors:  Karen Cilliers; Christo J F Muller
Journal:  Biol Trace Elem Res       Date:  2020-04-01       Impact factor: 3.738

10.  Effect of zinc salts on respiratory syncytial virus replication.

Authors:  Rahaman O Suara; James E Crowe
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.